Free Trial
NYSEAMERICAN:FOXO

FOXO Technologies Q4 2023 Earnings Report

FOXO Technologies logo
$0.22 -0.03 (-11.03%)
Closing price 06/13/2025 04:10 PM Eastern
Extended Trading
$0.24 +0.03 (+13.37%)
As of 06/13/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FOXO Technologies EPS Results

Actual EPS
-$2.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

FOXO Technologies Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

FOXO Technologies Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

FOXO Technologies' Q2 2025 earnings is scheduled for Monday, August 18, 2025, with a conference call scheduled on Sunday, August 17, 2025 at 6:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

FOXO Technologies Earnings Headlines

When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More FOXO Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like FOXO Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FOXO Technologies and other key companies, straight to your email.

About FOXO Technologies

FOXO Technologies (NYSEAMERICAN:FOXO) engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.

View FOXO Technologies Profile

More Earnings Resources from MarketBeat